Get Ready For a New
Cooperation!
The 1st network for stakeholders in European projects
Open Calls
See all Calls
Background Failure to translate research findings into policy and practice impedes research from achieving maximum public health benefit. New products and/or novel clinical interventions (i.e., new drug combinations/new formulations, clinical management algorithms), for poverty-related diseases (PRDs), may not reach the target populations, especially in resource-poor settings such as sub-Saharan ...
Background Poverty-related diseases (PRDs) remain the leading causes of morbidity and mortality in sub-Saharan Africa, especially during childhood. Despite progress in other age groups, effective treatment and prevention of PRDs in paediatric populations is often lacking and/or lagging. The frequent exclusion of children and adolescents from clinical trials and the paucity of available products t ...
Background Antimicrobials are designed to kill or stop the growth of disease-causing pathogens, but many of them have become increasingly ineffective due to emerging resistance by the targeted bacteria, viruses, protozoa or fungi. Selection pressure naturally leads to the emergence of resistance whenever microbes are exposed to agents who are meant to kill them or inhibit their growth, and the po ...
Background There is an urgent need for new or improved products for tackling poverty-related diseases (PRDs). Late phase clinical trials (Phase III/IV) are at a critical juncture between clinical development and market authorisation by the regulators. These trials, which provide evidence to support the product approval process and/or influence policy and practice, are often large in scale, comple ...
Ideas Proposed
See all Ideas
Interested in a Partnership (Avni Berisha)
14 hours ago
Latest Partners
See all Partners
Pikolab Engineering
11 hours ago
İzmir, Türkiye
Hermes4.0
13 hours ago
SIDERNO
Latest Consultants
See all Consultants
Esra Tahmaz
5 days ago
İstanbul, Türkiye
Pablo Marina
7 days ago
Sevilla, España
Try it
